Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide vs levetiracetam in drug‑resistant partial epilepsy
IRCT20210925052579N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of lacosamide and levetiracetam in Focal Onset Epilepsy (2 arms), sponsored by Isfahan University of Medical Sciences. Started Mar 2022; status: completed.
02
Drugs
lacosamidelevetiracetam
03
Conditions
Focal Onset Epilepsy
Beyond the preview
Go deeper on IRCT20210925052579N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210925052579N1.